MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: www.youtube.com/msviewsandnews -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~


Tuesday, April 19, 2011

European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of AVONEX® PEN™ for patients with relapsing multiple sclerosis (MS)



Biogen Idec announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of AVONEX® PEN for patients with relapsing multiple sclerosis (MS) and patients with a single demyelinating event. The CHMP recommendation provides the basis for a European Commission licensing decision, which is expected within 75 days from the opinion. The company also announced an authorisation for AVONEX PEN from Health Canada.

“AVONEX is currently one of the most prescribed first-line treatments for people living with MS and has more than 1.4 million patient years of experience. For many patients and their caregivers, AVONEX PEN is a significant advancement, especially for those who desire a more convenient method of administration”

AVONEX PEN is designed to be the first single-use, once-a-week, fully integrated intramuscular autoinjector available for use with AVONEX treatment. It has been designed to improve convenience of AVONEX administration, while also reducing injection anxiety. The CHMP decision was based, in part, on a Phase 3b study in which the overall success rate in using AVONEX PEN in patients with MS was 89 percent. In the study, 94 percent of patients expressed a preference for AVONEX PEN over the AVONEX Prefilled Syringe.

"AVONEX is currently one of the most prescribed first-line treatments for people living with MS and has more than 1.4 million patient years of experience. For many patients and their caregivers, AVONEX PEN is a significant advancement, especially for those who desire a more convenient method of administration," said Douglas E. Williams, Ph.D., executive vice president, research and development at Biogen Idec. "This positive CHMP opinion and authorisation in Canada is a testament to our commitment to not only develop new treatments for the MS community, but our continued drive to further improve patients' experience with our existing industry-leading therapies."

Source Biogen Idec

****************************************************************
Remain CURRENT with Multiple Sclerosis information 
 when registered at the  MS Views and News  website
.
***************************************************************************************
Help to Educate:  Please donate   - all contributions are tax deductible - 
.
"Providing You with 'MS Views and News'is what we do"
***************************************************************************************
.
Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
.
 ****************************************************************

No comments: